Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/29597
Type
ArticleCopyright
Restricted access
Embargo date
2028-08-30
Collections
- INI - Artigos de Periódicos [3464]
Metadata
Show full item record
NEVIRAPINE OR EFAVIRENZ FOR TUBERCULOSIS AND HIV COINFECTED PATIENTS: EXPOSURE AND VIROLOGICAL FAILURE RELATIONSHIP
Author
Affilliation
Ministério da Saúde. Instituto Nacional de Saúde. Maputo, Moçambique./ Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Epicentre. Paris, France.
Ministério da Saúde. Instituto Nacional de Saúde. Maputo, Moçambique.
Epicentre. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France./ University Paris Sud. Faculty of Pharmacy. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Epicentre. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France.
Epicentre. Paris, France.
Ministério da Saúde. Instituto Nacional de Saúde. Maputo, Moçambique.
Epicentre. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France./ University Paris Sud. Faculty of Pharmacy. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Epicentre. Paris, France.
Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Hôpitaux Universitaires Paris Sud, Clinical Pharmacy. Paris, France.
Abstract
We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial.
Share